Massachusetts General Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2016

  1. Comparison of Risk Prediction With the CKD-EPI and MDRD Equations in Non–ST-Segment Elevation Acute Coronary Syndrome

    Clinical Cardiology, Vol. 39, Núm. 9, pp. 507-515

2015

  1. Major bleeding risk prediction using Chronic Kidney Disease Epidemiology Collaboration and Modification of Diet in Renal Disease equations in acute coronary syndrome

    European Journal of Clinical Investigation, Vol. 45, Núm. 4, pp. 385-393

  2. Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

    American Heart Journal, Vol. 169, Núm. 5, pp. 631-638.e7

2013

  1. Beta-trace protein and cystatin C as predictors of major bleeding in non-ST-segment elevation acute coronary syndrome

    Circulation Journal, Vol. 77, Núm. 8, pp. 2088-2096

  2. β-trace protein: From GFR marker to cardiovascular risk predictor

    Clinical Journal of the American Society of Nephrology, Vol. 8, Núm. 5, pp. 873-881

2012

  1. Usefulness of β-trace protein and cystatin C for the prediction of mortality in non ST segment elevation acute coronary syndromes

    American Journal of Cardiology, Vol. 110, Núm. 9, pp. 1240-1248